Blockchain Registration Transaction Record

NRx Launches Revolutionary One-Day Depression Treatment in Florida

NRx Pharmaceuticals launches revolutionary one-day depression treatment in Florida clinics. New Ampa protocol shows 87% response rates, transforming TMS therapy for treatment-resistant depression.

This development represents a potential paradigm shift in mental health treatment, offering hope to millions suffering from treatment-resistant depression and PTSD. Traditional TMS therapy typically requires daily sessions over several weeks or months, creating significant barriers to access and compliance. The Ampa ONE-D protocol's ability to deliver comparable or superior results in a single day could dramatically reduce treatment burden, lower healthcare costs, and make effective care accessible to more patients. Given that depression affects over 280 million people globally and treatment-resistant cases represent up to 30% of depression patients, this innovation addresses a critical unmet medical need. The high response and remission rates demonstrated in studies suggest this approach could transform outcomes for patients who have exhausted conventional treatment options, potentially reducing suicide risk and improving quality of life for countless individuals and their families.